{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:16:07Z","timestamp":1787670967851,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10741-021-10184-9","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T06:08:56Z","timestamp":1636438136000},"page":"595-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Large animal models of heart failure with preserved ejection fraction"],"prefix":"10.1007","volume":"27","author":[{"given":"Chihiro","family":"Miyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyo","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid H.","family":"Karimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-8416","authenticated-orcid":false,"given":"Kiyotaka","family":"Fukamachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"10184_CR1","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Coats AJ, Tsutsui H et al (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail","DOI":"10.1002\/ejhf.2115"},{"key":"10184_CR2","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146\u2013e603","journal-title":"Circulation"},{"key":"10184_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251\u2013259","journal-title":"N Engl J Med"},{"key":"10184_CR4","doi-asserted-by":"crossref","unstructured":"Lam CSP, Gamble GD, Ling LH et al (2018) Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J 39:1770\u20131780","DOI":"10.1093\/eurheartj\/ehy005"},{"key":"10184_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ, Borlaug BA, Kitzman DW et al (2020) Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group summary. Circulation 141:1001\u20131026","journal-title":"Circulation"},{"key":"10184_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS et al (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381:1609\u20131620","journal-title":"N Engl J Med"},{"key":"10184_CR7","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","volume":"39","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ (2018) Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J 39:2780\u20132792","journal-title":"Eur Heart J"},{"key":"10184_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10741-018-9679-y","volume":"23","author":"KO Bonsu","year":"2018","unstructured":"Bonsu KO, Arunmanakul P, Chaiyakunapruk N (2018) Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison. Heart Fail Rev 23:147\u2013156","journal-title":"Heart Fail Rev"},{"key":"10184_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370:1383\u20131392","journal-title":"N Engl J Med"},{"key":"10184_CR10","doi-asserted-by":"crossref","unstructured":"Liu F, Chen Y, Feng X, Teng Z, Yuan Y, Bin J (2014) Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis. PLoS One 9:e90555","DOI":"10.1371\/journal.pone.0090555"},{"key":"10184_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2011.01.081","volume":"155","author":"M Fu","year":"2012","unstructured":"Fu M, Zhou J, Sun A et al (2012) Efficacy of ace inhibitors in chronic heart failure with preserved ejection fraction\u2013a meta analysis of 7 prospective clinical studies. Int J Cardiol 155:33\u201338","journal-title":"Int J Cardiol"},{"key":"10184_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138:861\u2013870","journal-title":"Circulation"},{"key":"10184_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2211-4122.199064","volume":"27","author":"O Issa","year":"2017","unstructured":"Issa O, Peguero JG, Podesta C et al (2017) Left atrial size and heart failure hospitalization in patients with diastolic dysfunction and preserved ejection fraction. J Cardiovasc Echogr 27:1\u20136","journal-title":"J Cardiovasc Echogr"},{"key":"10184_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","volume":"76","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, Obokata M, Verbrugge FH, Lin G, Borlaug BA (2020) Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J Am Coll Cardiol 76:1051\u20131064","journal-title":"J Am Coll Cardiol"},{"key":"10184_CR15","doi-asserted-by":"crossref","unstructured":"Beltrami M, Palazzuoli A, Padeletti L et al (2018) The importance of integrated left atrial evaluation: from hypertension to heart failure with preserved ejection fraction. Int J Clin Pract 72","DOI":"10.1111\/ijcp.13050"},{"key":"10184_CR16","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40:3297\u20133317","journal-title":"Eur Heart J"},{"key":"10184_CR17","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1038\/s41598-020-65255-y","volume":"10","author":"M Mishra","year":"2020","unstructured":"Mishra M, Muthuramu I, Kempen H, De Geest B (2020) Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension. Sci Rep 10:8382","journal-title":"Sci Rep"},{"key":"10184_CR18","doi-asserted-by":"publisher","first-page":"H771","DOI":"10.1152\/ajpheart.00282.2015","volume":"309","author":"JA Regan","year":"2015","unstructured":"Regan JA, Mauro AG, Carbone S et al (2015) A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II. Am J Physiol Heart Circ Physiol 309:H771\u2013H778","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10641963.2017.1346113","volume":"40","author":"J Yim","year":"2018","unstructured":"Yim J, Cho H, Rabkin SW (2018) Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the dahl salt sensitive model of hypertension. Clin Exp Hypertens 40:155\u2013166","journal-title":"Clin Exp Hypertens"},{"key":"10184_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","volume":"24","author":"G Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o G, Heinonen I, Louren\u00e7o AP, Duncker DJ, Falc\u00e3o-Pires I (2016) Animal models of heart failure with preserved ejection fraction. Neth Heart J 24:275\u2013286","journal-title":"Neth Heart J"},{"key":"10184_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/01.RES.38.3.172","volume":"38","author":"S Sasayama","year":"1976","unstructured":"Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB (1976) Adaptations of the left ventricle to chronic pressure overload. Circ Res 38:172\u2013178","journal-title":"Circ Res"},{"key":"10184_CR22","first-page":"H134","volume":"238","author":"WH Newman","year":"1980","unstructured":"Newman WH, Webb JG (1980) Adaptation of left ventricle to chronic pressure overload: response to inotropic drugs. Am J Physiol 238:H134\u2013H143","journal-title":"Am J Physiol"},{"key":"10184_CR23","first-page":"H949","volume":"251","author":"RJ Bache","year":"1986","unstructured":"Bache RJ, Alyono D, Sublett E, Dai XZ (1986) Myocardial blood flow in left ventricular hypertrophy developing in young and adult dogs. Am J Physiol 251:H949\u2013H956","journal-title":"Am J Physiol"},{"key":"10184_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI111351","volume":"73","author":"DE Vatner","year":"1984","unstructured":"Vatner DE, Homcy CJ, Sit SP, Manders WT, Vatner SF (1984) Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines. J Clin Invest 73:1473\u20131482","journal-title":"J Clin Invest"},{"key":"10184_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.CIR.79.4.872","volume":"79","author":"WH Gaasch","year":"1989","unstructured":"Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS (1989) Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 79:872\u2013883","journal-title":"Circulation"},{"key":"10184_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI116676","volume":"92","author":"J Zhang","year":"1993","unstructured":"Zhang J, Merkle H, Hendrich K et al (1993) Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 92:993\u20131003","journal-title":"J Clin Invest"},{"key":"10184_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/01.CIR.92.4.978","volume":"92","author":"L Hittinger","year":"1995","unstructured":"Hittinger L, Mirsky I, Shen YT, Patrick TA, Bishop SP, Vatner SF (1995) Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation 92:978\u2013986","journal-title":"Circulation"},{"key":"10184_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/01.RES.66.2.329","volume":"66","author":"L Hittinger","year":"1990","unstructured":"Hittinger L, Shannon RP, Kohin S, Manders WT, Kelly P, Vatner SF (1990) Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy. Circ Res 66:329\u2013343","journal-title":"Circ Res"},{"key":"10184_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/01.CIR.95.6.1601","volume":"95","author":"M Koide","year":"1997","unstructured":"Koide M, Nagatsu M, Zile MR et al (1997) Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95:1601\u20131610","journal-title":"Circulation"},{"key":"10184_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/01.RES.39.2.238","volume":"39","author":"SP Bishop","year":"1976","unstructured":"Bishop SP, Melsen LR (1976) Myocardial necrosis, fibrosis, and DNA synthesis in experimental cardiac hypertrophy induced by sudden pressure overload. Circ Res 39:238\u2013245","journal-title":"Circ Res"},{"key":"10184_CR31","first-page":"H983","volume":"264","author":"AM Fujii","year":"1993","unstructured":"Fujii AM, Aoyagi T, Flanagan MF et al (1993) Response of the hypertrophied left ventricle to tachycardia: importance of maturation. Am J Physiol 264:H983\u2013H993","journal-title":"Am J Physiol"},{"key":"10184_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.RES.0000179722.79295.d4","volume":"97","author":"LS Song","year":"2005","unstructured":"Song LS, Pi Y, Kim SJ et al (2005) Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy. Circ Res 97:457\u2013464","journal-title":"Circ Res"},{"key":"10184_CR33","doi-asserted-by":"publisher","first-page":"H1062","DOI":"10.1152\/ajpheart.00998.2010","volume":"300","author":"RJ Gelpi","year":"2011","unstructured":"Gelpi RJ, Park M, Gao S, Dhar S, Vatner DE, Vatner SF (2011) Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function. Am J Physiol Heart Circ Physiol 300:H1062\u2013H1068","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR34","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/01.CIR.103.11.1570","volume":"103","author":"Y Ye","year":"2001","unstructured":"Ye Y, Gong G, Ochiai K, Liu J, Zhang J (2001) High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation 103:1570\u20131576","journal-title":"Circulation"},{"key":"10184_CR35","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.01142.2002","volume":"285","author":"G Gong","year":"2003","unstructured":"Gong G, Liu J, Liang P et al (2003) Oxidative capacity in failing hearts. Am J Physiol Heart Circ Physiol 285:H541\u2013H548","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR36","doi-asserted-by":"publisher","first-page":"H1393","DOI":"10.1152\/ajpheart.00871.2005","volume":"290","author":"X Wang","year":"2006","unstructured":"Wang X, Hu Q, Mansoor A et al (2006) Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Am J Physiol Heart Circ Physiol 290:H1393\u2013H1405","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"114","key":"10184_CR37","first-page":"131","volume":"2013","author":"KD Marshall","year":"1985","unstructured":"Marshall KD, Muller BN, Krenz M et al (1985) Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function. J Appl Physiol 2013(114):131\u2013147","journal-title":"J Appl Physiol"},{"key":"10184_CR38","doi-asserted-by":"crossref","unstructured":"Hiemstra JA, Guti\u00e9rrez-Aguilar M, Marshall KD et al (2014) A new twist on an old idea part 2: cyclosporine preserves normal mitochondrial but not cardiomyocyte function in mini-swine with compensated heart failure. Physiol Rep 2","DOI":"10.14814\/phy2.12050"},{"key":"10184_CR39","doi-asserted-by":"crossref","unstructured":"Hiemstra JA, Liu S, Ahlman MA et al (2013) A new twist on an old idea: a two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction. Physiol Rep 1:e00174","DOI":"10.1002\/phy2.174"},{"issue":"124","key":"10184_CR40","first-page":"1034","volume":"2018","author":"JA Hiemstra","year":"1985","unstructured":"Hiemstra JA, Veteto AB, Lambert MD et al (1985) Chronic low-intensity exercise attenuates cardiomyocyte contractile dysfunction and impaired adrenergic responsiveness in aortic-banded mini-swine. J Appl Physiol 2018(124):1034\u20131044","journal-title":"J Appl Physiol"},{"key":"10184_CR41","doi-asserted-by":"crossref","unstructured":"Olver TD, Klakotskaia D, Ferguson BS et al (2016) Carotid artery vascular mechanics serve as biomarkers of cognitive dysfunction in aortic-banded miniature swine that can be treated with an exercise intervention. J Am Heart Assoc 5","DOI":"10.1161\/JAHA.116.003248"},{"key":"10184_CR42","doi-asserted-by":"crossref","unstructured":"Olver TD, Hiemstra JA, Edwards JC et al (2017) Loss of female sex hormones exacerbates cerebrovascular and cognitive dysfunction in aortic banded miniswine through a neuropeptide Y-Ca2+-activated potassium channel-nitric oxide mediated mechanism. J Am Heart Assoc 6","DOI":"10.1161\/JAHA.117.007409"},{"issue":"125","key":"10184_CR43","first-page":"86","volume":"2018","author":"TD Olver","year":"1985","unstructured":"Olver TD, Edwards JC, Ferguson BS et al (1985) Chronic interval exercise training prevents BK Ca channel-mediated coronary vascular dysfunction in aortic-banded miniswine. J Appl Physiol 2018(125):86\u201396","journal-title":"J Appl Physiol"},{"issue":"127","key":"10184_CR44","first-page":"816","volume":"2019","author":"A Ouyang","year":"1985","unstructured":"Ouyang A, Olver TD, Emter CA, Fleenor BS (1985) Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products. J Appl Physiol 2019(127):816\u2013827","journal-title":"J Appl Physiol"},{"key":"10184_CR45","doi-asserted-by":"publisher","first-page":"H1348","DOI":"10.1152\/ajpheart.00578.2010","volume":"299","author":"CA Emter","year":"2010","unstructured":"Emter CA, Baines CP (2010) Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine. Am J Physiol Heart Circ Physiol 299:H1348\u2013H1356","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR46","doi-asserted-by":"publisher","first-page":"H1687","DOI":"10.1152\/ajpheart.00610.2011","volume":"301","author":"CA Emter","year":"2011","unstructured":"Emter CA, Tharp DL, Ivey JR, Ganjam VK, Bowles DK (2011) Low-intensity interval exercise training attenuates coronary vascular dysfunction and preserves Ca2+-sensitive K+ current in miniature swine with LV hypertrophy. Am J Physiol Heart Circ Physiol 301:H1687\u2013H1694","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR47","doi-asserted-by":"publisher","first-page":"H450","DOI":"10.1152\/ajpheart.00072.2015","volume":"309","author":"Q Xiong","year":"2015","unstructured":"Xiong Q, Zhang P, Guo J, Swingen C, Jang A, Zhang J (2015) Myocardial atp hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophy. Am J Physiol Heart Circ Physiol 309:H450\u2013H458","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR48","doi-asserted-by":"crossref","unstructured":"Ishikawa K, Aguero J, Oh JG et al (2015) Increased stiffness is the major early abnormality in a pig model of severe aortic stenosis and predisposes to congestive heart failure in the absence of systolic dysfunction. J Am Heart Assoc 4","DOI":"10.1161\/JAHA.115.001925"},{"key":"10184_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacbts.2019.02.004","volume":"4","author":"TD Olver","year":"2019","unstructured":"Olver TD, Edwards JC, Jurrissen TJ et al (2019) Western diet-fed, aortic-banded Ossabaw swine: a preclinical model of cardio-metabolic heart failure. JACC Basic Transl Sci 4:404\u2013421","journal-title":"JACC Basic Transl Sci"},{"key":"10184_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jtcvs.2011.09.032","volume":"143","author":"WM Yarbrough","year":"2012","unstructured":"Yarbrough WM, Mukherjee R, Stroud RE et al (2012) Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature. J Thorac Cardiovasc Surg 143:215\u2013223","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10184_CR51","first-page":"92","volume":"7","author":"CJ Charles","year":"2020","unstructured":"Charles CJ, Lee P, Li RR et al (2020) A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics. ESC Heart Fail 7:92\u2013102","journal-title":"ESC Heart Fail"},{"key":"10184_CR52","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3109\/10641969609081034","volume":"18","author":"CJ Charles","year":"1996","unstructured":"Charles CJ, Kaaja RJ, Espiner EA et al (1996) Natriuretic peptides in sheep with pressure overload left ventricular hypertrophy. Clin Exp Hypertens 18:1051\u20131071","journal-title":"Clin Exp Hypertens"},{"key":"10184_CR53","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-017-15851-2","volume":"7","author":"M Wallner","year":"2017","unstructured":"Wallner M, Eaton DM, Berretta RM et al (2017) A feline hfpef model with pulmonary hypertension and compromised pulmonary function. Sci Rep 7:16587","journal-title":"Sci Rep"},{"key":"10184_CR54","doi-asserted-by":"crossref","unstructured":"Wallner M, Eaton DM, Berretta RM et al (2020) HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction. Sci Transl Med 12","DOI":"10.1126\/scitranslmed.aay7205"},{"key":"10184_CR55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12967-017-1299-0","volume":"15","author":"M Gy\u00f6ngy\u00f6si","year":"2017","unstructured":"Gy\u00f6ngy\u00f6si M, Pavo N, Lukovic D et al (2017) Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension. J Transl Med 15:202","journal-title":"J Transl Med"},{"key":"10184_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.89.2308.273","volume":"89","author":"IH Page","year":"1939","unstructured":"Page IH (1939) A method for producing persistent hypertension by cellophane. Science 89:273\u2013274","journal-title":"Science"},{"key":"10184_CR57","doi-asserted-by":"crossref","unstructured":"Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347\u2013379","DOI":"10.1084\/jem.59.3.347"},{"key":"10184_CR58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/01.RES.42.4.543","volume":"42","author":"TM Mueller","year":"1978","unstructured":"Mueller TM, Marcus ML, Kerber RE, Young JA, Barnes RW, Abboud FM (1978) Effect of renal hypertension and left ventricular hypertrophy on the coronary circulation in dogs. Circ Res 42:543\u2013549","journal-title":"Circ Res"},{"key":"10184_CR59","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/jappl.1971.31.4.635","volume":"31","author":"CM Ferrario","year":"1971","unstructured":"Ferrario CM, Blumle C, Nadzam GR, McCubbin JW (1971) An externally adjustable renal artery clamp. J Appl Physiol 31:635\u2013637","journal-title":"J Appl Physiol"},{"key":"10184_CR60","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1161\/01.CIR.82.3.941","volume":"82","author":"KC Dellsperger","year":"1990","unstructured":"Dellsperger KC, Martins JB, Clothier JL, Marcus ML (1990) Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade. Circulation 82:941\u2013950","journal-title":"Circulation"},{"key":"10184_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/01.CIR.92.1.106","volume":"92","author":"J Donckier","year":"1995","unstructured":"Donckier J, Stoleru L, Hayashida W et al (1995) Role of endogenous endothelin-1 in experimental renal hypertension in dogs. Circulation 92:106\u2013113","journal-title":"Circulation"},{"key":"10184_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0008-6363(96)00194-0","volume":"33","author":"W Hayashida","year":"1997","unstructured":"Hayashida W, Donckier J, Van Mechelen H, Charlier AA, Pouleur H (1997) Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Cardiovasc Res 33:54\u201362","journal-title":"Cardiovasc Res"},{"key":"10184_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/01.CIR.104.2.215","volume":"104","author":"CY Hart","year":"2001","unstructured":"Hart CY, Meyer DM, Tazelaar HD et al (2001) Load versus humoral activation in the genesis of early hypertensive heart disease. Circulation 104:215\u2013220","journal-title":"Circulation"},{"key":"10184_CR64","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/01.CIR.0000157183.21404.63","volume":"111","author":"VK Munagala","year":"2005","unstructured":"Munagala VK, Hart CY, Burnett JC Jr, Meyer DM, Redfield MM (2005) Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure. Circulation 111:1128\u20131135","journal-title":"Circulation"},{"key":"10184_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/HYPERTENSIONAHA.107.099010","volume":"51","author":"BP Shapiro","year":"2008","unstructured":"Shapiro BP, Owan TE, Mohammed S et al (2008) Mineralocorticoid signaling in transition to heart failure with normal ejection fraction. Hypertension 51:289\u2013295","journal-title":"Hypertension"},{"key":"10184_CR66","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/cvr\/cvs353","volume":"97","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfield MM, Linke WA (2013) Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res 97:464\u2013471","journal-title":"Cardiovasc Res"},{"key":"10184_CR67","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","volume":"102","author":"CG Brilla","year":"2000","unstructured":"Brilla CG, Funck RC, Rupp H (2000) Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102:1388\u20131393","journal-title":"Circulation"},{"key":"10184_CR68","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","volume":"113","author":"L van Heerebeek","year":"2006","unstructured":"van Heerebeek L, Borb\u00e9ly A, Niessen HW et al (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113:1966\u20131973","journal-title":"Circulation"},{"key":"10184_CR69","unstructured":"Abrahams C, Janicki JS, Weber KT (1987) Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix. Lab Invest 56:676\u201383"},{"key":"10184_CR70","first-page":"H1384","volume":"255","author":"CM Cimini","year":"1988","unstructured":"Cimini CM, Weiss HR (1988) Microvascular morphometry and perfusion in renal hypertension-induced cardiac hypertrophy. Am J Physiol 255:H1384\u2013H1390","journal-title":"Am J Physiol"},{"key":"10184_CR71","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jmri.25423","volume":"45","author":"R Mazumder","year":"2017","unstructured":"Mazumder R, Schroeder S, Mo X, Clymer BD, White RD, Kolipaka A (2017) In-vivo quantification of myocardial stiffness in hypertensive porcine hearts using magnetic resonance elastography. J Magn Reson Imaging 45:813\u2013820","journal-title":"J Magn Reson Imaging"},{"key":"10184_CR72","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/cvr\/cvy038","volume":"114","author":"O Sorop","year":"2018","unstructured":"Sorop O, Heinonen I, van Kranenburg M et al (2018) Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res 114:954\u2013964","journal-title":"Cardiovasc Res"},{"key":"10184_CR73","doi-asserted-by":"publisher","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","volume":"290","author":"JL Grobe","year":"2006","unstructured":"Grobe JL, Mecca AP, Mao H, Katovich MJ (2006) Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290:H2417\u2013H2423","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR74","first-page":"303s","volume":"3","author":"JM Terris","year":"1976","unstructured":"Terris JM, Berecek KH, Cohen EL, Stanley JC, Whitehouse WM Jr, Bohr DF (1976) Deoxycorticosterone hypertension in the pig. Clin Sci Mol Med Suppl 3:303s\u2013305s","journal-title":"Clin Sci Mol Med Suppl"},{"key":"10184_CR75","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/01.HYP.1.6.591","volume":"1","author":"AW Miller 2nd","year":"1979","unstructured":"Miller AW 2nd, Bohr DF, Schork AM, Terris JM (1979) Hemodynamic responses to DOCA in young pigs. Hypertension 1:591\u2013597","journal-title":"Hypertension"},{"key":"10184_CR76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3181\/00379727-171-41480","volume":"171","author":"JM Terris","year":"1982","unstructured":"Terris JM, Simmonds RC (1982) The Yucatan miniature swine: an improved pig model for the study of desoxycorticosterone-acetate (DOCA) and aldosterone hypertension. Proc Soc Exp Biol Med 171:79\u201382","journal-title":"Proc Soc Exp Biol Med"},{"key":"10184_CR77","doi-asserted-by":"crossref","unstructured":"Sweadner KJ, Herrera VL, Amato S, Moellmann A, Gibbons DK, Repke KR (1994) Immunologic identification of Na+,K(+)-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res 74:669\u201378","DOI":"10.1161\/01.RES.74.4.669"},{"key":"10184_CR78","doi-asserted-by":"publisher","first-page":"H1407","DOI":"10.1152\/ajpheart.00542.2015","volume":"309","author":"M Schwarzl","year":"2015","unstructured":"Schwarzl M, Hamdani N, Seiler S et al (2015) A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 309:H1407\u2013H1418","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR79","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12968-016-0283-9","volume":"18","author":"U Reiter","year":"2016","unstructured":"Reiter U, Reiter G, Manninger M et al (2016) Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:63","journal-title":"J Cardiovasc Magn Reson"},{"key":"10184_CR80","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/joa.13117","volume":"236","author":"C M\u00fchlfeld","year":"2020","unstructured":"M\u00fchlfeld C, Rajces A, Manninger M et al (2020) A transmural gradient of myocardial remodeling in early-stage heart failure with preserved ejection fraction in the pig. J Anat 236:531\u2013539","journal-title":"J Anat"},{"key":"10184_CR81","doi-asserted-by":"crossref","unstructured":"Nachar W, Merlet N, Maafi F et al (2019) Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits. PLoS One 14:e0220707","DOI":"10.1371\/journal.pone.0220707"},{"key":"10184_CR82","first-page":"743","volume":"34","author":"MMP van den Dorpel","year":"2018","unstructured":"van den Dorpel MMP, Heinonen I, Snelder SM et al (2018) Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction. Int J Cardiovasc Imaging 34:743\u2013749","journal-title":"Int J Cardiovasc Imaging"},{"key":"10184_CR83","doi-asserted-by":"publisher","first-page":"H2002","DOI":"10.1152\/ajpheart.2001.281.5.H2002","volume":"281","author":"SJ Dong","year":"2001","unstructured":"Dong SJ, Hees PS, Siu CO, Weiss JL, Shapiro EP (2001) MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau. Am J Physiol Heart Circ Physiol 281:H2002\u2013H2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR84","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.jacc.2019.02.045","volume":"73","author":"JF Huizar","year":"2019","unstructured":"Huizar JF, Ellenbogen KA, Tan AY, Kaszala K (2019) Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73:2328\u20132344","journal-title":"J Am Coll Cardiol"},{"key":"10184_CR85","doi-asserted-by":"publisher","first-page":"H725","DOI":"10.1152\/ajpheart.00440.2013","volume":"305","author":"DJ Dosdall","year":"2013","unstructured":"Dosdall DJ, Ranjan R, Higuchi K et al (2013) Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs. Am J Physiol Heart Circ Physiol 305:H725\u2013H731","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10184_CR86","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cardiores.2003.12.013","volume":"61","author":"A Bauer","year":"2004","unstructured":"Bauer A, McDonald AD, Donahue JK (2004) Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure. Cardiovasc Res 61:764\u2013770","journal-title":"Cardiovasc Res"},{"key":"10184_CR87","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10741-020-10067-5","volume":"26","author":"C Miyagi","year":"2021","unstructured":"Miyagi C, Miyamoto T, Karimov JH, Starling RC, Fukamachi K (2021) Device-based treatment options for heart failure with preserved ejection fraction. Heart Fail Rev 26:749\u2013762","journal-title":"Heart Fail Rev"},{"key":"10184_CR88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-019-0985-z","volume":"19","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Soga F, Tatsumi K et al (2020) Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure. Cardiovasc Diabetol 19:6","journal-title":"Cardiovasc Diabetol"},{"key":"10184_CR89","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10741-019-09787-0","volume":"24","author":"A Burlacu","year":"2019","unstructured":"Burlacu A, Simion P, Nistor I, Covic A, Tinica G (2019) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review. Heart Fail Rev 24:793\u2013803","journal-title":"Heart Fail Rev"},{"key":"10184_CR90","doi-asserted-by":"crossref","unstructured":"Kiamanesh O, Rankin K, Billia F, Badiwala MV (2020) Left ventricular assist device with a left atrial inflow cannula for hypertrophic cardiomyopathy. JACC: Case Reports 2:2090\u20132094","DOI":"10.1016\/j.jaccas.2020.10.006"},{"key":"10184_CR91","doi-asserted-by":"crossref","unstructured":"Wintrich J, Kindermann I, Ukena C et al (2020)Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol","DOI":"10.1007\/s00392-020-01633-w"},{"key":"10184_CR92","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jtcvs.2019.12.110","volume":"162","author":"K Fukamachi","year":"2021","unstructured":"Fukamachi K, Horvath DJ, Karimov JH et al (2021) Left atrial assist device to treat patients with heart failure with preserved ejection fraction: initial in vitro study. J Thorac Cardiovasc Surg 162:120\u2013126","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10184_CR93","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10439-020-02492-2","volume":"48","author":"A Escher","year":"2020","unstructured":"Escher A, Choi Y, Callaghan F et al (2020) A valveless pulsatile pump for heart failure with preserved ejection fraction: hemo- and fluid dynamic feasibility. Ann Biomed Eng 48:1821\u20131836","journal-title":"Ann Biomed Eng"},{"key":"10184_CR94","doi-asserted-by":"crossref","unstructured":"Hiemstra JA, Lee DI, Chakir K et al (2016) Saxagliptin and tadalafil differentially alter cyclic guanosine monophosphate (cGMP) signaling and left ventricular function in aortic-banded mini-swine. J Am Heart Assoc e003277","DOI":"10.1161\/JAHA.116.003277"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10184-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T02:20:05Z","timestamp":1675909205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10184"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10184-9","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"21 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kiyotaka Fukamachi, Jamshid H. Karimov, and Randall C. Starling are co-inventors of the LAAD. The other coauthors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}